Glimepiride and Antivert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glimepiride (glimepiride) and Antivert (meclizine hydrochloride). Common drug interactions include anxiety among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Glimepiride and Antivert. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.



On Jul, 13, 2026

25 people who take Glimepiride and Antivert together, and have interactions are studied.

Glimepiride and Antivert drug interactions.

What are the common drug interactions of Glimepiride and Antivert, by gender? *:

female:

  1. Anxiety
  2. Cardiac disorder
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Depression
  5. Foot fracture
  6. Migraine (headache)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteoporosis (bones weak and more likely to break)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Tricuspid valve disease (disease of heart valve)

male:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Balance disorder
  5. Blood potassium increased
  6. Cheilitis (infection of lips)
  7. Chest discomfort
  8. Cough
  9. Decreased activity
  10. Depressed mood

What are the common drug interactions of Glimepiride and Antivert, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Cardiac disorder
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Foot fracture
  7. Migraine (headache)
  8. Oedema (fluid collection in tissue)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Insomnia (sleeplessness)
  4. Lymphocyte count decreased
  5. Mouth haemorrhage (bleeding from mouth)
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Pyrexia (fever)
  8. Rash
  9. Skin atrophy (wasting of skin)
  10. Vomiting

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 24.00%
  2. High Blood Pressure: 6 people, 24.00%
  3. Chest Pain: 3 people, 12.00%
  4. Nausea (feeling of having an urge to vomit): 3 people, 12.00%
  5. Hypertensive Heart Disease: 2 people, 8.00%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 8.00%
  7. Constipation: 2 people, 8.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
  9. High Blood Cholesterol: 2 people, 8.00%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and Antivert?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glimepiride and Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glimepiride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glimepiride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Antivert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glimepiride and meclizine hydrochloride (the active ingredients of Glimepiride and Antivert, respectively), and Glimepiride and Antivert (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: